Ladone Mary Kay 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Ladone Mary Kay
Director
Transactions
- Award
Common Shares
2025-09-04+10,909→ 23,903 total
Footnotes (2)
- [F1]The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.
- [F2]Includes 12,994 restricted common shares of the Issuer that were automatically converted in connection with the Issuer's initial public offering from Class A Common Units of West Affum Holdings, L.P. previously held by the Reporting Person which were originally granted on October 7, 2024. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares will vest on October 7, 2025, 4,331 restricted common shares will vest on October 7, 2026 and 4,332 restricted common shares will vest on October 7, 2027.